Park Place Capital’s Mural Oncology MURA Stock Holding History

Park Place Capital’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-62	Closed	-$194	–	853
2024 Q3	$194	Buy	+62	New	+$202	﹤0.01%	853

Other funds holding MURA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Park Place Capital's MURA Position: Q4 2024 in Review

Park Place Capital sold out of Mural Oncology (MURA) in Q4 2024, closing a stake of 62 shares — an estimated $194 sold.

Park Place Capital first reported a position in MURA in Q3 2024 and held it in 1 quarter. The position peaked at $194 in Q3 2024. 76 funds tracked by Wall St. Rank hold MURA as of Q4 2024.

Park Place Capital reported no remaining Mural Oncology position as of Q4 2024 after selling out during the quarter.
Park Place Capital sold 62 Mural Oncology shares in Q4 2024, an estimated $194.
Park Place Capital first reported a position in Mural Oncology in Q3 2024 and held it in 1 quarter.
Park Place Capital's Mural Oncology position peaked at $194 in Q3 2024.
76 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2024.

Based on Park Place Capital's 13F filing for Q4 2024, filed 17 Jan 2025.